ACS Infectious Diseases p. 303 - 315 (2019)
Update date:2022-08-05
Topics:
Kumar, Malkeet
Okombo, John
Mambwe, Dickson
Taylor, Dale
Lawrence, Nina
Reader, Janette
Van Der Watt, Mari?tte
Fontinha, Diana
Sanches-Vaz, Margarida
Bezuidenhout, Belinda C.
Lauterbach, Sonja B.
Liebenberg, Dale
Birkholtz, Lyn-Marie
Coetzer, Theresa L.
Prudêncio, Miguel
Egan, Timothy J.
Wittlin, Sergio
Chibale, Kelly
A drug repositioning approach was leveraged to derivatize astemizole (AST), an antihistamine drug whose antimalarial activity was previously identified in a high-throughput screen. The multistage activity potential against the Plasmodium parasite's life cycle of the subsequent analogues was examined by evaluating against the parasite asexual blood, liver, and sexual gametocytic stages. In addition, the previously reported contribution of heme detoxification to the compound's mode of action was interrogated. Ten of the 17 derivatives showed half-maximal inhibitory concentrations (IC50s) of <0.1 μM against the chloroquine (CQ)-sensitive Plasmodium falciparum NF54 (PfNF54) strain while maintaining submicromolar potency against the multidrug-resistant strain, PfK1, with most showing low likelihood of cross-resistance with CQ. Selected analogues (PfNF54-IC50 < 0.1 μM) were tested for cytotoxicity on Chinese hamster ovarian (CHO) cells and found to be highly selective (selectivity index > 100). Screening of AST and its analogues against gametocytes revealed their moderate activity (IC50: 1-5 μM) against late stage P. falciparum gametocytes, while the evaluation of activity against P. berghei liver stages identified one compound (3) with 3-fold greater activity than the parent AST compound. Mechanistic studies showed a strong correlation between in vitro inhibition of β-hematin formation by the AST derivatives and their antiplasmodium IC50s. Analyses of intracellular inhibition of hemozoin formation within the parasite further yielded signatures attributable to a possible perturbation of the heme detoxification machinery.
View MoreShanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
shanghai Tauto Biotech Co., Ltd
website:http://www.tautobiotech.com/en/index.htm
Contact:+86-21-51320588 ext. 8025
Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
SHANGHAI ARCADIA BIOTECHNOLOGY LTD.
Contact:+86-21-61353236
Address:SUITE 901, BUILDING WENSLI, 1378 LU JIA BANG RD, SHANGAHI 200011, P.R.CHINA
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Contact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Doi:10.1021/jo00117a001
(1995)Doi:10.1016/j.bioorg.2020.103852
(2020)Doi:10.1039/jr9550000083
(1955)Doi:10.1081/CAR-120037571
(2004)Doi:10.1002/hlca.19510340737
(1951)Doi:10.1016/S0040-4039(01)90387-9
(1981)